DJIA 17,524.67 84.08 0.48%
NASDAQ 5,047.46 7.68 0.15%
S&P 500 2,079.26 11.62 0.56%
market minute promo

Gilead Sciences (NASDAQ: GILD)

111.33 0.79 (0.71%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $111.36 0.74%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $112.52
Previous Close $110.54
Daily Range $110.74 - $112.95
52-Week Range $85.95 - $123.37
Market Cap $163.6B
P/E Ratio 12.59
Dividend (Yield) $1.72 (1.6%)
Ex-Dividend Date
Dividend Pay Date
06/12/15
06/29/15
Volume 3,989,110
Average Daily Volume 10,212,241
Current FY EPS $11.04

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary

Are These 2 Big Pharmas Really Buyout Candidates?

AstraZeneca and Bristol-Myers Squibb's names have both repeatedly surfaced on the buyout rumor mill this year. Do these rumors have legs, or are they nothing more than speculation?

The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and Exp

The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and Express Scripts - Press Releases

Gilead: Will Single-Tablet HIV Regimens Drive Sentiment?

AbbVie: Viekira Pak Sales Not Likely To Hit $3 Billion Run Rate By Year End

3 Big Biotech Buybacks That Investors Should Love

Big biotech companies are flush with cash and are using it to reward shareholders. Here are three companies that are spending big on share buybacks.

Earnings Scheduled For July 28, 2015

10 Stocks You Should Be Watching Today

Great Stocks for Baby Boomers

Fed Meeting, Twitter Earnings, Consumer Data in Focus Tuesday

3 Stocks for Retirees to Buy

Retirees should be looking for rock-solid businesses that offer good long-term growth prospects and shareholder friendly management teams. Here are 3 company's that fit the bill today.

See More GILD News...

GILD's Top Competitors

GILD $111.33 (0.71%)
Current stock: GILD
AMGN $171.15 (3.39%)
Current stock: AMGN
CELG $134.08 (1.15%)
Current stock: CELG
$0.00 (0.00%)
Current stock: